Compare, Analyse Novartis with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs ACTAVIS (US) - Comparison Results

NOVARTIS     Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 NOVARTIS   ACTAVIS
EQUITY SHARE DATA
    NOVARTIS
Mar-19
ACTAVIS
Dec-18
NOVARTIS/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs98014,269-   
Low Rs6009,571-   
Sales per share (Unadj.) Rs198.73,500.1-  
Earnings per share (Unadj.) Rs21.0-1,127.4-  
Cash flow per share (Unadj.) Rs22.3368.8-  
Dividends per share (Unadj.) Rs10.000-  
Dividend yield (eoy) %1.30-  
Book value per share (Unadj.) Rs307.514,436.3-  
Shares outstanding (eoy) m24.69332.60-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.03.4 116.7%   
Avg P/E ratio x37.7-10.6 -356.4%  
P/CF ratio (eoy) x35.532.3 109.8%  
Price / Book Value ratio x2.60.8 311.2%  
Dividend payout %47.70-   
Avg Mkt Cap Rs m19,5083,964,616 0.5%   
No. of employees `0000.616.9 3.4%   
Total wages/salary Rs m1,1710-   
Avg. sales/employee Rs Th8,445.468,883.6 12.3%   
Avg. wages/employee Rs Th2,015.70-   
Avg. net profit/employee Rs Th891.0-22,187.4 -4.0%   
INCOME DATA
Net Sales Rs m4,9071,164,133 0.4%  
Other income Rs m78322,262 3.5%   
Total revenues Rs m5,6891,186,395 0.5%   
Gross profit Rs m12330,506 0.4%  
Depreciation Rs m32497,642 0.0%   
Interest Rs m1667,177 0.0%   
Profit before tax Rs m858-512,051 -0.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0130,594 0.0%   
Tax Rs m340-6,489 -5.2%   
Profit after tax Rs m518-374,968 -0.1%  
Gross profit margin %2.52.6 95.5%  
Effective tax rate %39.61.3 3,128.0%   
Net profit margin %10.6-32.2 -32.8%  
BALANCE SHEET DATA
Current assets Rs m8,055477,467 1.7%   
Current liabilities Rs m1,850422,383 0.4%   
Net working cap to sales %126.44.7 2,672.3%  
Current ratio x4.41.1 385.1%  
Inventory Days Days4520 229.9%  
Debtors Days Days3466 51.1%  
Net fixed assets Rs m150131,773 0.1%   
Share capital Rs m1230-   
"Free" reserves Rs m7,4690-   
Net worth Rs m7,5924,801,506 0.2%   
Long term debt Rs m01,690,784 0.0%   
Total assets Rs m9,8247,505,847 0.1%  
Interest coverage x54.9-6.6 -829.7%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.50.2 322.0%   
Return on assets %5.4-4.1 -132.5%  
Return on equity %6.8-7.8 -87.3%  
Return on capital %11.5-4.8 -237.7%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m-1,2690-   
CASH FLOW
From Operations Rs m-1,943415,901 -0.5%  
From Investments Rs m2,742228,483 1.2%  
From Financial Activity Rs m-298-713,811 0.0%  
Net Cashflow Rs m501-69,080 -0.7%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 73.74 Rs / USD

Compare NOVARTIS With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare NOVARTIS With: PIRAMAL ENTERPRISES  GLENMARK PHARMA  CIPLA  JUBILANT LIFE SCIENCES  STRIDES PHARMA SCIENCE  



Today's Market

Sensex Ends Flat; Maruti Suzuki Rallies 7.5%(Closing)

After opening the day at record high levels, Indian share markets erased gains as the session progressed and ended on a flat note, led by a decline in IT stocks and index heavyweight HDFC Bank.

Related Views On News

NOVARTIS Announces Quarterly Results (3QFY20); Net Profit Down 39.9% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, NOVARTIS has posted a net profit of Rs 77 m (down 39.9% YoY). Sales on the other hand came in at Rs 1 bn (down 13.4% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

NOVARTIS Announces Quarterly Results (1QFY20); Net Profit Down 92.1% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, NOVARTIS has posted a net profit of Rs 8 m (down 92.1% YoY). Sales on the other hand came in at Rs 1 bn (down 20.8% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

More Views on News

Most Popular

Not Infosys or Wipro. India's Next Wealth Creators Could Be Drone Stocks (Profit Hunter)

Nov 25, 2020

India's drones directorate signals the next big defence tech multibaggers.

It's Time to Book Profits (Fast Profits Daily)

Nov 27, 2020

In my first video on Equitymaster, I want to introduce you my proprietary greed and fear index. It's telling us to book some profits in the market.

How the New Margins Will Impact You (Fast Profits Daily)

Nov 25, 2020

The new rules on margins will come into effect from 1st December. Are you ready?

Create Wealth for Yourself in India's Drone Revolution (Profit Hunter)

Nov 27, 2020

The Chinese drone market is 14 times that of India's. Billions may flow into Indian drone companies too. Don't miss out on this wealth creating opportunity.

The Price of Dying, the Cost of Living (The Honest Truth)

Nov 20, 2020

Ajit Dayal presents a cost benefit analysis of the various types of response to covid around the world.

More
-->

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

NOVARTIS SHARE PRICE


Dec 3, 2020 (Close)

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON NOVARTIS

NOVARTIS - PFIZER COMPARISON

COMPARE NOVARTIS WITH

FEATURED VIDEOS

Adani Green: A Future Multibagger or a Big, Speculative Bubble

Is M&M the ITC of Auto Sector?

Don't Let Brokerages Fool You into Buying HUL & Nestle. The Real Money is in These Stocks Right Now...

What to Expect from Stocks during Covid Second Wave?

More Featured Videos

MARKET STATS